Table 2 Summary of transplanted... | American Society of Hematology

Table 2

Summary of transplanted population, development of leukemia, and frequency of leukemic-initiating population

Experimental design		No. of mice developing leukemia (latency in days)
No. of cells transplanted	No. of mice per group	Bulk	MPP	CMP	GMP	GMP-L	MEP	B220⁺CD19⁺
1 000 000	2	2 (27 ± 2)	2 (21 ± 2)	2 (33 ± 1)	2(33 ± 0)	0	0	0
100 000	4	4 (33 ± 1)	4 (35 ± 1)	4 (34 ± 0)	4 (42 ± 2)	0	0	0
10 000	6	6 (39 ± 2)	6 (33 ± 1)	6 (76 ± 13)	5 (61 ± 8)	0	0	0
1000	6	6 (40 ± 1)	6 (42 ± 7)	0	0	0	0	0
100	6	2 (152 + 20)	6 (71 ± 3)	0	0	0	0	0
10	6	0	2 (85 ± 5)	0	0	0	0	0
Frequency of LIC in sorted population		1:234	1:22	1:4,341	1:7,212	NA	NA	NA

Experimental design		No. of mice developing leukemia (latency in days)
No. of cells transplanted	No. of mice per group	Bulk	MPP	CMP	GMP	GMP-L	MEP	B220⁺CD19⁺
1 000 000	2	2 (27 ± 2)	2 (21 ± 2)	2 (33 ± 1)	2(33 ± 0)	0	0	0
100 000	4	4 (33 ± 1)	4 (35 ± 1)	4 (34 ± 0)	4 (42 ± 2)	0	0	0
10 000	6	6 (39 ± 2)	6 (33 ± 1)	6 (76 ± 13)	5 (61 ± 8)	0	0	0
1000	6	6 (40 ± 1)	6 (42 ± 7)	0	0	0	0	0
100	6	2 (152 + 20)	6 (71 ± 3)	0	0	0	0	0
10	6	0	2 (85 ± 5)	0	0	0	0	0
Frequency of LIC in sorted population		1:234	1:22	1:4,341	1:7,212	NA	NA	NA

NA indicates not applicable.